The global demand for Radioembolization Therapy Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Radioembolization therapy is a combination of radiation therapy and a procedure called embolization to treat liver cancer. Radioembolization therapy involves placing radioactive material directly inside the body. In radioembolization therapy, tiny glass or resin beads called microspheres are put inside the blood vessels that feed a tumor to cut off the blood supply to the cancer cells. Once these microspheres, filled with the radioactive isotope yttrium Y-90, become lodged at the tumor site, they give a high dose of radiation to the tumor and not to normal tissues. The form of treatment is known as internal radiation therapy.
The global market for radioembolization therapy is anticipated to grow because of the increasing incidence of several types of hepatic cancer and the rising demand for a minimally invasive procedure. Moreover, the expanding expenditure to improve healthcare infrastructure and the growing research and development activities in the healthcare sector for technology related advancements are expected to propel the growth of the radioembolization therapy market. Besides that, initiatives taken by the government, such as funding and grants for the development of advanced techniques using interventional oncology, will drive the market growth. However, the availability of effective conventional first-level therapies to treat liver cancer, uterine fibroids, hemorrhagic stroke, and other conditions can be a key restraint to market growth.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of radioembolization therapy. The growth and trends of radioembolization therapy industry provide a holistic approach to this study.
This section of the radioembolization therapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
- Transarterial Radioembolization (TARE)
- Selective Internal Radiation Therapy (SIRT)
By End User
- Hepatocellular Carcinoma
- Liver Cancer
- Ambulatory Surgical Centers
This section covers the regional outlook, which accentuates current and future demand for the Radioembolization Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Radioembolization Therapy Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the radioembolization therapy market include Terumo Corporation, Merit Medical Systems Inc., Cook Medical, Boston Scientific Corporation, Medtronic plc, Stryker Corporation, Depuy Synthes (J&J), BTG International Limited, Others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.